Volatile organic compounds (VOCs) in COPD patients with exacerbation

V. Besa, K. Darwiche, H. Teschler, U. Sommerwerck, I. Kurth, T. Rabis, J. I. Baumbach, L. Freitag (Essen, Saarbruecken, Germany)

Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Session: Role of the biomarkers in airway diseases
Session type: Poster Discussion
Number: 4788
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Besa, K. Darwiche, H. Teschler, U. Sommerwerck, I. Kurth, T. Rabis, J. I. Baumbach, L. Freitag (Essen, Saarbruecken, Germany). Volatile organic compounds (VOCs) in COPD patients with exacerbation. Eur Respir J 2011; 38: Suppl. 55, 4788

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Volatile organic compounds (VOC) in exhaled breath of patients with COPD
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010

Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function
Source: International Congress 2015 – The next generation of lung function tests
Year: 2015



Volatile organic compounds (VOCs) in exhaled air of patients with lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 208s
Year: 2003

Breath volatile organic compound (VOC) patterns in adult asthma patients of the ALLIANCE cohort
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019

Volatile organic compounds in exhaled breath are associated with exacerbations in children with asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009

Microbial volatile organic compounds (MVOC) and plasticizers in schools in relation to asthma and respiratory symptoms among pupils
Source: Eur Respir J 2006; 28: Suppl. 50, 698s
Year: 2006

Volatile organic compound (VOC) analysis to differentiate between bacterial and viral respiratory infections in COPD
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018




Diet and alcohol affect exhaled volatile organic compounds (VOCs)
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010

Breath volatile organic compound (VOC) COPD study at two DZL centers - Evaluation of site-specific VOC
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015

Presence of volatile organic compounds (VOC) in exhaled breath in patients diagnosed with lung cancer (LC) vs healthy patients. Preliminary data
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010

Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010

Volatile organic compounds in COPD: Is hexanal an inflammation biomarker?
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016


Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016

Concentration profile of persistent organic pollutants (POPs) in blood serum of patients with COPD
Source: Annual Congress 2010 - Chemical exposures and respiratory effects
Year: 2010

Multiple detectable exhaled volatile organic compounds (vocs) may serve as potential inflammatory biomarkers in COPD
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009


Volatile organic compounds (VOC) in exhaled air sampled through the working channel of a bronchoscope in lung cancer patients
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010

Exhaled volatile organic compounds as markers for medication use in asthma
Source: Eur Respir J, 55 (2) 1900544; 10.1183/13993003.00544-2019
Year: 2020



Breath volatile organic compounds and inflammatory markers in adult asthma patients: negative results from the ALLIANCE cohort
Source: Eur Respir J, 57 (2) 2002127; 10.1183/13993003.02127-2020
Year: 2021



Standardization of exhaled volatile organic compounds (VOCs) measurement
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010